Achilles Therapeutics Plc (ACHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Operating Expenses | 75,255 | 78,383 | 64,195 | 33,727 | 13,775 |
| Operating Income | -75,255 | -78,383 | -64,195 | -33,727 | -13,775 |
| Other Income | 6,081 | 7,318 | 3,133 | 531 | -215 |
| Pre-tax Income | -69,174 | -71,065 | -61,062 | -33,196 | -13,990 |
| Income Tax | 491 | 111 | 37 | 3 | N/A |
| Net Income Continuous | -69,665 | -71,176 | -61,099 | -33,199 | -13,990 |
| Net Income | $-69,665 | $-71,176 | $-61,099 | $-33,199 | $-13,990 |
| EPS Basic Total Ops | -1.74 | -1.82 | -2.13 | -31.14 | -5.50 |
| EPS Basic Continuous Ops | -1.74 | -1.82 | -2.13 | -31.14 | -5.50 |
| EPS Diluted Total Ops | -1.74 | -1.82 | -2.13 | -31.14 | -5.50 |
| EPS Diluted Continuous Ops | -1.74 | -1.82 | -2.13 | -31.14 | -5.50 |
| EPS Diluted Before Non-Recurring Items | -1.74 | -1.82 | -2.13 | N/A | N/A |
| EBITDA(a) | $-70,542 | $-74,693 | $-60,907 | $-32,955 | $-13,473 |